Diane Weiser | VP, IR & Corporate Communications |
Robert Blum | CEO, President & Director |
Fady Malik | EVP, Research & Development |
Andrew Wolff | SVP & Chief Medical Officer |
Peter Roddy | SVP & CAO |
Ching Jaw | SVP & CFO |
Matthew Harrison | Morgan Stanley |
Chad Messer | Needham & Company |
Jason Butler | JMP Securities |
Charles Duncan | Piper Jaffray Companies |
Vernon Bernardino | Seaport Global Securities |
Good afternoon, and welcome, ladies and gentlemen, to the Cytokinetics First Quarter 2018 Conference Call. At this time, I would like to inform you that this call is being recorded. [Operator Instructions]. I will now turn the call over to Diane Weiser, Cytokinetics Vice President of Corporate Communications and Investor Relations. Please go ahead.